Full Report

Format

Full Report
Summary (Text)
Summary (XML)

Send to:

Choose Destination

File
Clipboard
Collections

Childhood myelodysplastic syndrome

MedGen UID:: 389541
•Concept ID:: C2347761
•: Neoplastic Process

Synonyms:	childhood MDS; Childhood Myelodysplastic Syndrome; childhood myelodysplastic syndrome
SNOMED CT:	Childhood myelodysplastic syndrome (705061009)

Monarch Initiative:	MONDO:0044873

Definition

An uncommon hematologic malignancy occurring during childhood. Many of the morphologic, immunophenotypic, and genetic changes seen in adult myelodysplastic syndromes are also observed in the childhood variants of the disease. Children present with neutropenia and thrombocytopenia more often than adults, and bone marrow hypocellularity is more often seen in children than adults. [from NCI]

Term Hierarchy

GTR
MeSH

CClinical test, RResearch test, OOMIM, GGeneReviews, VClinVar

CROGVChildhood myelodysplastic syndrome

Pathological process
- Disease
  - Neoplasm
    - Neoplasm by Special Category
      - Childhood neoplasm
        Childhood malignant neoplasm
        Childhood myelodysplastic syndrome
        Refractory cytopenia of childhood

Professional guidelines

PubMed

Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.

Loh ML
Hematology Am Soc Hematol Educ Program 2010;2010:357-62. doi: 10.1182/asheducation-2010.1.357. PMID: 21239819

Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry.

Locatelli F, Zecca M, Niemeyer C, Angelucci E, Arcese G, Bender-Gotze C, Bonetti F, Burdach S, Dini G, Ebell W, Friedrich W, Hasle H, Hermann J, Jacobsen N, Klingebiel T, Kremens B, Mann G, Miniero R, Pession A, Peters C, Paolucci P, Rossetti F, Schmid HJ, Stary J, Zimmermann M
Bone Marrow Transplant 1996 Nov;18 Suppl 2:63-8. PMID: 8932802

See all (2)

Recent clinical studies

Etiology

Prospective validation of the provisional entity of refractory cytopenia of childhood, proposed by the World Health Organization.

Hama A, Hasegawa D, Manabe A, Nozawa K, Narita A, Muramatsu H, Kosaka Y, Kobayashi M, Koh K, Takahashi Y, Watanabe K, Ohara A, Ito M, Kojima S
Br J Haematol 2022 Feb;196(4):1031-1039. Epub 2021 Nov 3 doi: 10.1111/bjh.17921. PMID: 34729770

Improved outcomes of allogeneic hematopoietic stem cell transplantation including haploidentical transplantation for childhood myelodysplastic syndrome.

Yoo JW, Im HJ, Kim H, Koh KN, Kang SH, Min SY, Choi ES, Jang S, Park CJ, Seo JJ
Bone Marrow Transplant 2020 Aug;55(8):1595-1603. Epub 2020 Feb 13 doi: 10.1038/s41409-020-0814-8. PMID: 32054998

Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?

Zuo Y, Cheng Y, Zhang L, Qin Y, Luo H
Hematology 2019 Dec;24(1):480-486. doi: 10.1080/16078454.2019.1631507. PMID: 31210595

Differences in the bone marrow histology between childhood myelodysplastic syndrome with multilineage dysplasia and refractory cytopenia of childhood without multilineage dysplasia.

Iwafuchi H, Ito M
Histopathology 2019 Jan;74(2):239-247. Epub 2018 Oct 29 doi: 10.1111/his.13721. PMID: 30062702

Childhood myelodysplastic syndrome.

Chatterjee T, Choudhry VP
Indian J Pediatr 2013 Sep;80(9):764-71. Epub 2013 Aug 3 doi: 10.1007/s12098-013-1130-8. PMID: 23912822

See all (15)

Diagnosis

Childhood Myelodysplastic Syndrome.

Chisholm KM, Bohling SD
Clin Lab Med 2023 Dec;43(4):639-655. Epub 2023 Aug 7 doi: 10.1016/j.cll.2023.06.005. PMID: 37865508

Prospective validation of the provisional entity of refractory cytopenia of childhood, proposed by the World Health Organization.

Childhood myelodysplastic syndrome.

Chatterjee T, Choudhry VP
Indian J Pediatr 2013 Sep;80(9):764-71. Epub 2013 Aug 3 doi: 10.1007/s12098-013-1130-8. PMID: 23912822

Genetic analysis of TP53 in childhood myelodysplastic syndrome and juvenile myelomonocytic leukemia.

Saito S, Matsuda K, Taira C, Sano K, Tanaka-Yanagisawa M, Yanagisawa R, Nakazawa Y, Sakashita K, Shiohara M, Koike K
Leuk Res 2011 Dec;35(12):1578-84. Epub 2011 Jul 23 doi: 10.1016/j.leukres.2011.06.027. PMID: 21784522

Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.

Loh ML
Hematology Am Soc Hematol Educ Program 2010;2010:357-62. doi: 10.1182/asheducation-2010.1.357. PMID: 21239819

See all (22)

Therapy

Wilms' tumor 1 mRNA expression: a good tool for differentiating between myelodysplastic syndrome and aplastic anemia in children?

Zuo Y, Cheng Y, Zhang L, Qin Y, Luo H
Hematology 2019 Dec;24(1):480-486. doi: 10.1080/16078454.2019.1631507. PMID: 31210595

Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.

Hama A, Takahashi Y, Muramatsu H, Ito M, Narita A, Kosaka Y, Tsuchida M, Kobayashi R, Ito E, Yabe H, Ohga S, Ohara A, Kojima S
Haematologica 2015 Nov;100(11):1426-33. Epub 2015 Aug 13 doi: 10.3324/haematol.2015.128553. PMID: 26273061 Free PMC Article

Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood.

Aalbers AM, van den Heuvel-Eibrink MM, Baumann I, Dworzak M, Hasle H, Locatelli F, De Moerloose B, Schmugge M, Mejstrikova E, Nováková M, Zecca M, Zwaan CM, Te Marvelde JG, Langerak AW, van Dongen JJ, Pieters R, Niemeyer CM, van der Velden VH
Haematologica 2015 Mar;100(3):315-23. Epub 2014 Nov 25 doi: 10.3324/haematol.2014.107706. PMID: 25425683 Free PMC Article

Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome.

Göhring G, Michalova K, Beverloo HB, Betts D, Harbott J, Haas OA, Kerndrup G, Sainati L, Bergstraesser E, Hasle H, Stary J, Trebo M, van den Heuvel-Eibrink MM, Zecca M, van Wering ER, Fischer A, Noellke P, Strahm B, Locatelli F, Niemeyer CM, Schlegelberger B
Blood 2010 Nov 11;116(19):3766-9. Epub 2010 Aug 27 doi: 10.1182/blood-2010-04-280313. PMID: 20802024

Intensive chemotherapy in childhood myelodysplastic syndrome. A comparison with results in acute myeloid leukemia.

Hasle H, Kerndrup G, Yssing M, Clausen N, Ostergaard E, Jacobsen N, Jacobsen BB
Leukemia 1996 Aug;10(8):1269-73. PMID: 8709630

See all (7)

Prognosis

Childhood myelodysplastic syndrome.

Chatterjee T, Choudhry VP
Indian J Pediatr 2013 Sep;80(9):764-71. Epub 2013 Aug 3 doi: 10.1007/s12098-013-1130-8. PMID: 23912822

Childhood myelodysplastic syndrome: focus on the approach to diagnosis and treatment of juvenile myelomonocytic leukemia.

Loh ML
Hematology Am Soc Hematol Educ Program 2010;2010:357-62. doi: 10.1182/asheducation-2010.1.357. PMID: 21239819

The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).

Hasle H, Baumann I, Bergsträsser E, Fenu S, Fischer A, Kardos G, Kerndrup G, Locatelli F, Rogge T, Schultz KR, Starý J, Trebo M, van den Heuvel-Eibrink MM, Harbott J, Nöllke P, Niemeyer CM; European Working Group on childhood MDS
Leukemia 2004 Dec;18(12):2008-14. doi: 10.1038/sj.leu.2403489. PMID: 15496981

A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada.

Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR
Br J Haematol 1999 Sep;106(4):1027-32. doi: 10.1046/j.1365-2141.1999.01645.x. PMID: 10520007

Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions.

Hasle H, Kerndrup G, Jacobsen BB
Leukemia 1995 Sep;9(9):1569-72. PMID: 7658725

See all (14)

Clinical prediction guides

Improved outcomes of allogeneic hematopoietic stem cell transplantation including haploidentical transplantation for childhood myelodysplastic syndrome.

Yoo JW, Im HJ, Kim H, Koh KN, Kang SH, Min SY, Choi ES, Jang S, Park CJ, Seo JJ
Bone Marrow Transplant 2020 Aug;55(8):1595-1603. Epub 2020 Feb 13 doi: 10.1038/s41409-020-0814-8. PMID: 32054998

Comparison of long-term outcomes between children with aplastic anemia and refractory cytopenia of childhood who received immunosuppressive therapy with antithymocyte globulin and cyclosporine.

Childhood myelodysplastic syndrome.

Chatterjee T, Choudhry VP
Indian J Pediatr 2013 Sep;80(9):764-71. Epub 2013 Aug 3 doi: 10.1007/s12098-013-1130-8. PMID: 23912822

Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome.

The International Prognostic Scoring System (IPSS) for childhood myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML).

See all (10)